These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19644728)

  • 1. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.
    Bate C; Tayebi M; Salmona M; Diomede L; Williams A
    Neurotox Res; 2010 Apr; 17(3):203-14. PubMed ID: 19644728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42.
    Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A
    Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.
    Bate C; Tayebi M; Williams A
    Mol Neurodegener; 2010 Apr; 5():13. PubMed ID: 20374666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
    Last V; Williams A; Werling D
    BMC Neurosci; 2012 Aug; 13():106. PubMed ID: 22928663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phospholipase A2 increased the removal of the prion derived peptide PrP82-146 from cultured neurons.
    Bate C; Ingham V; Williams A
    Neuropharmacology; 2011; 60(2-3):365-72. PubMed ID: 20934441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
    Bate C; Tayebi M; Williams A
    Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro.
    Bate C; Rutherford S; Gravenor M; Reid S; Williams A
    Neuroreport; 2002 Oct; 13(15):1933-8. PubMed ID: 12395095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons.
    Pillot T; Drouet B; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Chambaz J
    J Neurochem; 2000 Dec; 75(6):2298-308. PubMed ID: 11080181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of cellular prion protein (PrPC) is related with activation of alpha7 nicotinic acetylcholine receptor (α7nAchR)-mediated autophagy flux.
    Jeong JK; Park SY
    Oncotarget; 2015 Sep; 6(28):24660-74. PubMed ID: 26295309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal and transynaptic spread of prions.
    Shearin H; Bessen RA
    J Virol; 2014 Aug; 88(15):8640-55. PubMed ID: 24850738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation.
    Xiao Y; Li X
    Brain Res; 1999 Oct; 846(1):112-21. PubMed ID: 10536218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ₁₋₄₀) administration in mice.
    Rial D; Piermartiri TC; Duarte FS; Tasca CI; Walz R; Prediger RD
    Neuroscience; 2012 Jul; 215():79-89. PubMed ID: 22537845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-synuclein induced synapse damage is enhanced by amyloid-β1-42.
    Bate C; Gentleman S; Williams A
    Mol Neurodegener; 2010 Dec; 5():55. PubMed ID: 21138585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.